The receptor for advanced glycation end products and its ligands: A new inflammatory pathway in lung disease?

Modern Pathology

Volumn 19, Issue 11, 2006, Pages 1437-1445

  Morbini, Patrizia ^a   Villa, Chiara ^a   Campo, Ilaria ^a   Zorzetto, Michele ^a   Inghilleri, Simona ^a   Luisetti, Maurizio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

AGE; Lung inflammation; RAGE; s100 calgranulin

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; PROTEIN; PROTEIN S10012; PROTEIN S100B; UNCLASSIFIED DRUG;

ARTICLE; BRONCHIOLE; CELL AGGREGATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM; FIBROBLAST; GRANULOCYTE; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; MACROPHAGE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AIRWAY OBSTRUCTION; GRANULOMA, RESPIRATORY TRACT; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LUNG; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; LYSINE; NERVE GROWTH FACTORS; PNEUMONIA; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SMOKING;

EID: 33750303583     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800661     Document Type: Article

References (35)

1. Schmidt AM, Yan SD, Yan SF, et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-955.
2. Yan SF, Ramasamy R, Naka Y, et al. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003;93:1159-1169.
3. Ritthaler U, Deng Y, Zhang Y, et al. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 1995;146:688-694.
4. Cipollone F, Iezzi A, Fazia M, et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 2003;108:1070-1077.
5. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
6. Hofmann MA, Drury S, Hudson BI, et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 2002;3:123-135.
7. Brownlee M. The pathological implications of protein glycation. Clin Invest Med 1995;18:275-281.
8. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540-551.
9. Foell D, Kane D, Bresnihan B, et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology 2003;42:1383-1389.
10. Foell D, Seeliger S, Vogl T, et al. Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 2003;58:613-617.
11. Foell D, Kucharzik T, Kraft M, et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003;52:847-853.
12. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992;267:14998-15004.
13. Schmidt AM, Vianna M, Gerlach M, et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 1992;267:14987-14989.
14. Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993;143:1699-1712.
15. Katsuoka F, Kawakami Y, Arai T, et al. Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. Biochem Biophys Res Commun 1997;238:512-516.
16. Shirasawa M, Fujiwara N, Hirabayashi S, et al. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 2004;9:165-174.
17. Cheng C, Tsuneyama K, Kominami R, et al. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod Pathol 2005;18:1385-1396.
18. Kinnula VL. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 2005;60:693-700.
19. Seagrave J. Oxidative mechanisms in tobacco smoke-induced emphysema. J Toxicol Environ Health A 2000;61:69-78.
20. Kinnula VL. Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy 2005;4:465-470.
21. Kinnula VL, Fattman CL, Tan RJ, et al. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005;172:417-422.
22. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
23. Campo I, Morbini P, Zorzetto M, et al. Expression of receptor for advanced glycation end-products in sarcoid granulomas. Submitted.
24. Uchida T, Shirasawa M, Ware LB, et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006 (E-pub ahead of print).
25. Ling X, Sakashita N, Takeya M, et al. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues. Lab Invest 1998;78:1591-1606.
26. Matsuse T, Ohga E, Teramoto S, et al. Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis. J Clin Pathol 1998;51:515-519.
27. Lakari E, Soini Y, Saily M, et al. Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. Am J Clin Pathol 2002;117:132-142.
28. Kuwano K, Nakashima N, Inoshima I, et al. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur Respir J 2003;21:232-240.
29. Lee KY, Ito K, Hayashi R, et al. NF-{kappa}B and activator protein 1 response elements and the role of histone modifications in IL-1{beta}-Induced TGF-{beta}1 gene transcription. J Immunol 2006;176:603-615.
30. Chapman HA. Disorders of lung matrix remodeling. J Clin Invest 2004;113:148-157.
31. Antoniou KM, Alexandrakis MG, Siafakas NM, et al. Cytokine network in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:91-104.
32. Katz J, Caudle RM, Bhattacharyya I, et al. Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine. J Periodontol 2005;76:1171-1174.
33. Schlueter C, Hauke S, Flohr AM, et al. Tissue-specific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing? Biochim Biophys Acta 2003;1630:1-6.
34. Yonekura H, Yamamoto Y, Sakurai S, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003;370:1097-1109.
35. Hogg CJ, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.